Gildan Activewear Inc. (GIL) experienced a sharp decline in its stock price on Tuesday, dropping over 20% on the New York Stock Exchange to $48.50, as a short seller report raised serious questions about the company's revenue quality and inventory levels. The selloff was triggered by Jehoshaphat Research, which disclosed a short position and accused the apparel manufacturer of engaging in channel stuffing—a practice where a company ships more products to distributors than end-user demand justifies—to inflate reported sales.
Short Seller Allegations and Market Reaction
Jehoshaphat's report alleged that Gildan's organic growth is significantly weaker than officially reported and that distributors are burdened with approximately $510 million in excess inventory. These claims, though unproven, struck at a sensitive area for investors already concerned about the company's wholesale performance. In its first-quarter results, Gildan reported an 11.9% year-over-year decline in wholesale sales, attributing the weakness to inventory reduction efforts by customers. The short seller's allegations amplify these concerns, suggesting that the reported figures may not accurately reflect underlying demand.
The market's reaction was swift and severe. Gildan's shares on the NYSE fell as low as $46.56 during heavy trading, while on the Toronto Stock Exchange, the stock dropped approximately 20% to CA$68.96. This decline occurred even as the broader S&P/TSX Composite Index edged higher, nearing record levels, highlighting the stock-specific nature of the selloff.
Impact on 2026 Guidance and Financial Health
The short report casts a shadow over Gildan's 2026 outlook, which management had maintained. The company continues to target net sales of $6.0 billion to $6.2 billion, adjusted diluted earnings per share of $4.20 to $4.40, and free cash flow exceeding $850 million. However, the first quarter saw a free cash flow burn of approximately $310 million, and net debt stood at $4.87 billion, resulting in a leverage ratio of 3.3 times net debt to pro forma adjusted EBITDA—a level that restricts financial flexibility.
Investors are now likely to scrutinize management's cash flow projections more closely. The high debt load leaves little room for error, and any deviation from the guidance could trigger further selling. Despite the stock trading at roughly 11 times the 2026 adjusted EPS target—a level that might appear cheap—the recent allegations and steep selloff have introduced significant risk.
Focus Shifts to Second-Quarter Results
All eyes are now on Gildan's second-quarter earnings report, expected around July 30. The company has guided for approximately $1.6 billion in net sales for the quarter, but it has also warned that lower channel inventory will continue to weigh on sell-in volumes. Investors will be looking for concrete updates on channel inventory levels, margin trends, and progress on cost synergies from the HanesBrands integration.
Analyst Brian Morrison of TD Cowen has maintained a Buy rating and an $80 price target, citing potential long-term benefits from the HanesBrands acquisition and EPS growth. However, the short seller report has introduced a layer of uncertainty that may require stronger evidence from management to reassure the market.
In summary, Gildan Activewear faces a pivotal moment. The short seller's allegations have not been proven, but they have exposed vulnerabilities in the company's narrative. The upcoming quarterly report will be critical in determining whether the stock can recover or if further declines are in store.
